122 related articles for article (PubMed ID: 21542955)
21. Long-term clinical follow-up after sirolimus-eluting stent versus bare metal stent implantation in patients with acute coronary syndrome.
Ogita M; Nakamura T; Fujiwara N; Sakakura K; Funayama H; Sugawara Y; Kubo N; Ako J; Momomura S
J Interv Cardiol; 2009 Jun; 22(3):216-21. PubMed ID: 19490360
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK;
J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
Abe M; Kimura T; Morimoto T; Taniguchi T; Yamanaka F; Nakao K; Yagi N; Kokubu N; Kasahara Y; Kataoka Y; Otsuka Y; Kawamura A; Miyazaki S; Nakao K; Horiuchi K; Ito A; Hoshizaki H; Kawaguchi R; Setoguchi M; Inada T; Kishi K; Sakamoto H; Morioka N; Imai M; Shiomi H; Nonogi H; Mitsudo K;
Circulation; 2010 Jul; 122(1):42-51. PubMed ID: 20566954
[TBL] [Abstract][Full Text] [Related]
24. Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study.
Park DW; Kim YH; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Her SH; Hur SH; Park JS; Kim MK; Choi YS; Kim HS; Cho JH; Lee SG; Park YW; Jeong MH; Lee BK; Lee NH; Lim DS; Yoon J; Seung KB; Shin WY; Rha SW; Kim KS; Tahk SJ; Park BE; Ahn T; Yang JY; Jeong YS; Rhew JH; Park SJ;
Circ Cardiovasc Interv; 2012 Jun; 5(3):365-71. PubMed ID: 22693347
[TBL] [Abstract][Full Text] [Related]
25. [The incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease in the real world: a single center registry study].
Chen JL; Yang YJ; Huang JH; Qin XW; Qiao SB; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Dec; 35(12):1133-5. PubMed ID: 18341817
[TBL] [Abstract][Full Text] [Related]
26. [Long-term efficacy of sirolimus-eluting stents (Cypher) versus bare metal stents for patients with ST-segment elevation myocardial infarction].
Ge YG; Zhang DP; Yang XC; Wang LF; Wang HS; Li WM; Xu L; Ni ZH; Lian Y; Xue YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):108-12. PubMed ID: 19099944
[TBL] [Abstract][Full Text] [Related]
27. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
28. Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry.
Damman P; Abdel-Wahab M; Möllmann H; Richardt G; Chevalier B; Barragan P; Tijssen JG; Underwood P; Hamm CW
J Invasive Cardiol; 2012 Oct; 24(10):495-502. PubMed ID: 23043032
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry.
Saia F; Piovaccari G; Manari A; Santarelli A; Benassi A; Aurier E; Sangiorgio P; Tarantino F; Geraci G; Vecchi G; Guastaroba P; Grilli R; Marzocchi A
J Am Coll Cardiol; 2006 Oct; 48(7):1312-8. PubMed ID: 17010788
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
Campo G; Saia F; Percoco G; Manari A; Santarelli A; Vignali L; Varani E; Benassi A; Sangiorgio P; Tarantino F; Magnavacchi P; De Palma R; Guastaroba P; Marzocchi A
Int J Cardiol; 2010 Apr; 140(2):154-60. PubMed ID: 19056134
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
32. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
[TBL] [Abstract][Full Text] [Related]
33. Comparison of drug-eluting stents with bare metal stents implantation for the treatment of acute ST-elevation myocardial infarction: 2-year clinical outcomes from single-center registry.
Li Y; Han YL; Zhang QY; Guan SY; Wang XZ; Jing QM; Ma YY; Wang G; Wang B; Deng J
Chin Med J (Engl); 2011 Mar; 124(6):825-30. PubMed ID: 21518587
[TBL] [Abstract][Full Text] [Related]
34. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Urban P; Gershlick AH; Guagliumi G; Guyon P; Lotan C; Schofer J; Seth A; Sousa JE; Wijns W; Berge C; Deme M; Stoll HP;
Circulation; 2006 Mar; 113(11):1434-41. PubMed ID: 16534015
[TBL] [Abstract][Full Text] [Related]
35. Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction.
Gao H; Yan HB; Zhu XL; Li N; Ai H; Wang J; Li SY; Yang D
Chin Med J (Engl); 2007 May; 120(10):863-7. PubMed ID: 17543174
[TBL] [Abstract][Full Text] [Related]
36. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.
Jeremias A; Ruisi CP; Kirtane AJ; Lee T; Sylvia B; Pinto DS; Ho KK; Cutlip DE; Carrozza JP; Cohen DJ
Coron Artery Dis; 2008 Mar; 19(2):111-5. PubMed ID: 18300748
[TBL] [Abstract][Full Text] [Related]
37. Long-term efficacy and safety of sirolimus-eluting vs bare-metal stents.
McKay RG; Murphy DJ; Cloutier J; Mather JF; Mennett RA; Dada MR; Shah AR; Kiernan FJ
Conn Med; 2008 Sep; 72(8):453-63. PubMed ID: 18798379
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy comparison of primary percutaneous coronary intervention with biodegradable polymer- and durable polymer-based sirolimus-eluting stents for patients with acute myocardial infarction].
Li Q; Wang LF; Yang XC; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Xia K
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Oct; 38(10):886-90. PubMed ID: 21176630
[TBL] [Abstract][Full Text] [Related]
39. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
[TBL] [Abstract][Full Text] [Related]
40. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
